Sotyktu

BMS puts discounted Sotyktu at the center of next DTC platform

BMS' new platform arrives on the heels of the launch of another online direct-to-patient program offering discounted Eliquis to certain U.S. patients.

Andrea Park Sep 25, 2025 11:01am

Trial results enhance BMS bid for Sotyktu in psoriatic arthritis

Mar 10, 2025 8:38am

JPM25: Takeda touts 6 pipeline assets with big sales potential

Jan 15, 2025 3:17pm

Sotyktu has excelled in 2 psoriatic arthritis trials, BMS says

Dec 23, 2024 11:25am

CEO says BMS can handle impact of IRA price negotiation

Jul 26, 2024 11:36am

Bristol Myers’ top challenges, as seen by analysts

Jul 12, 2024 12:00pm